ellagic-acid
发表于 2025-3-25 04:40:02
https://doi.org/10.1007/978-3-662-06599-0 a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice .
冲突
发表于 2025-3-25 10:31:06
http://reply.papertrans.cn/16/1541/154037/154037_22.png
WAIL
发表于 2025-3-25 11:41:29
Die Kollapstherapie der Lungentuberkulose,(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
纬线
发表于 2025-3-25 16:59:17
The Role of O2 Transport in the Development of the Transfusion Trigger(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
手段
发表于 2025-3-25 20:39:53
http://reply.papertrans.cn/16/1541/154037/154037_25.png
含沙射影
发表于 2025-3-26 00:46:28
Evidence-Based Transfusion Medicine or the Need to Evaluate Clinical Outcome a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice .
Distribution
发表于 2025-3-26 04:44:57
The Development of Synthocytes™, a Novel Platelet Substituteet transfusion include a reduced risk of blood borne virus transmission, no risk of alloimmunogenic reactions, an increased shelf life and therefore a more cost effective, more easily managed therapy.
phlegm
发表于 2025-3-26 09:09:57
Conference proceedings 1998development of alternative approaches in thisrapidly developing area. In clinical medicine conventional blood andits components are used in supportive therapies dependent on thechoice of apparent uncritical trigger factors. A compounding factor isdepth of prospective clinical trials for evidence. Su
flutter
发表于 2025-3-26 15:59:38
http://reply.papertrans.cn/16/1541/154037/154037_29.png
tenosynovitis
发表于 2025-3-26 17:08:21
Warum es diese Patientenleitlinie gibt,perative haemoglobin level or platelet transfusion level, the preferences of opinion leaders in the local clinical community , the availability of a transfusion committee with an authoritative surveillance system, variations in supply or in local or regional risks or public perceptions of those risks.